Understanding kidney care needs and implementation strategies in low- and middle-income countries: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

Vivekanand Jha; Mustafa Arici; Allan J. Collins; Guillermo Garcia-Garcia; Brenda R. Hemmelgarn; Tazeen H. Jafar; Roberto Pecoits-Filho; Laura Sola; Charles R. Swanepoel; Irma Tchokhonelidze; Angela Yee Moon Wang; Bertram L. Kasiske; David C. Wheeler; Goce Spasovski; Lawrence Agodoa; Ghazali Ahmad; Vathsala Anantharaman; Fatiu Arogundade; Gloria Ashuntantang; Sudarshan Ballal; Ebun Bamgboye; Chatri Banchuin; Boris Bogov; Sakarn Bunnag; Worawon Chailimpamontri; Ratana Chawanasuntorapoj; Rolando Claure-Del Granado; Somchai Eiam-Ong; Lynn Gomez; Rafael Gómez; Dimitrios Goumenos; Hai An Ha Phan; Valentine Imonje; Atiporn Ingsathit; Faiçal Jarraya; Sirin Jiwakanon; Surasak Kantachuvesiri; Umesh Khanna; Vijay Kher; Kamol Kitositrangsikun; Zhi Hong Liu; Pichet Lorvinitnun; Nazaire Nseka; Gregorio T. Obrador; Ikechi Okpechi; Duangta Onsuwan; Vuddhidej Ophascharoensuk; Charlotte Osafo; David Peiris; Warangkana Pichaiwong; Kearkiat Praditpornsilpa; Mohan Rajapurkar; Ivan Rychlik; Gamal Saadi; Vicente Sanchez Polo; Pornpen Sangthawan; Nirut Suwan; Vladimir Tesar; Prapaipim Thirakhupt; Thananda Trakarnvanich; Yusuke Tsukamoto; Kriang Tungsanga; Supat Vanichakarn; Evgueniy Vazelov; Christoph Wanner; Anthony Were; Elena Zakharova

doi:10.1016/j.kint.2016.09.009

Understanding kidney care needs and implementation strategies in low- and middle-income countries: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

Vivekanand Jha, Mustafa Arici, Allan J. Collins, Guillermo Garcia-Garcia, Brenda R. Hemmelgarn, Tazeen H. Jafar, Roberto Pecoits-Filho, Laura Sola, Charles R. Swanepoel, Irma Tchokhonelidze, Angela Yee Moon Wang, Bertram L. Kasiske, David C. Wheeler, Goce Spasovski, Lawrence Agodoa, Ghazali Ahmad, Vathsala Anantharaman, Fatiu Arogundade, Gloria Ashuntantang, Sudarshan BallalEbun Bamgboye, Chatri Banchuin, Boris Bogov, Sakarn Bunnag, Worawon Chailimpamontri, Ratana Chawanasuntorapoj, Rolando Claure-Del Granado, Somchai Eiam-Ong, Lynn Gomez, Rafael Gómez, Dimitrios Goumenos, Hai An Ha Phan, Valentine Imonje, Atiporn Ingsathit, Faiçal Jarraya, Sirin Jiwakanon, Surasak Kantachuvesiri, Umesh Khanna, Vijay Kher, Kamol Kitositrangsikun, Zhi Hong Liu, Pichet Lorvinitnun, Nazaire Nseka, Gregorio T. Obrador, Ikechi Okpechi, Duangta Onsuwan, Vuddhidej Ophascharoensuk, Charlotte Osafo, David Peiris, Warangkana Pichaiwong, Kearkiat Praditpornsilpa, Mohan Rajapurkar, Ivan Rychlik, Gamal Saadi, Vicente Sanchez Polo, Pornpen Sangthawan, Nirut Suwan, Vladimir Tesar, Prapaipim Thirakhupt, Thananda Trakarnvanich, Yusuke Tsukamoto, Kriang Tungsanga, Supat Vanichakarn, Evgueniy Vazelov, Christoph Wanner, Anthony Were, Elena Zakharova

Medicine - Renal and Hypertension Division

Research output: Contribution to journal › Article › peer-review

54 Scopus citations

Abstract

Evidence-based cinical practice guidelines improve delivery of uniform care to patients with and at risk of developing kidney disease, thereby reducing disease burden and improving outcomes. These guidelines are not well-integrated into care delivery systems in most low- and middle-income countries (LMICs). The KDIGO Controversies Conference on Implementation Strategies in LMIC reviewed the current state of knowledge in order to define a road map to improve the implementation of guideline-based kidney care in LMICs. An international group of multidisciplinary experts in nephrology, epidemiology, health economics, implementation science, health systems, policy, and research identified key issues related to guideline implementation. The issues examined included the current kidney disease burden in the context of health systems in LMIC, arguments for developing policies to implement guideline-based care, innovations to improve kidney care, and the process of guideline adaptation to suit local needs. This executive summary serves as a resource to guide future work, including a pathway for adapting existing guidelines in different geographical regions.

Original language	English (US)
Pages (from-to)	1164-1174
Number of pages	11
Journal	Kidney international
Volume	90
Issue number	6
DOIs	https://doi.org/10.1016/j.kint.2016.09.009
State	Published - Dec 1 2016

Bibliographical note

Funding Information:
VJ declared having received research support from Baxter and GlaxoSmithKline. AJC declared having received consultancy fees from AstraZeneca, Bayer, Gilead, and Relypsa. GG-G declared having received consultancy fees from Pisa Farmaceutica and speaker honoraria from Abbvie. THJ declared having received research support from Wellcome Trust UK, Medical Research Council, Department for International Development, and Singapore Ministry of Health. RP-F declared having received consultancy fees from Akebia and Janssen; speaker honoraria from AstraZeneca, Janssen, and Novartis; and research support from Fresenius. CRS declared having received consultancy fees from Fresenius. AYMW declared having received speaker honoraria from Sanofi. DCW declared having received consultancy fees from Akebia, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, GlaxoSmithKline, Janssen, Otsuka, UCB Celltech, and Vifor; speaker honoraria from Amgen, Fresenius, Janssen, Vifor, and ZS Pharma; and research support from British Heart Foundation, Healthcare Quality Improvement Partnership, Kidney Research UK, National Institute for Health Research, and Australian National Health & Medical Research Council. All the other authors declared no competing interests.

Funding Information:
The conference was sponsored by KDIGO and supported in part by unrestricted educational grants from Fresenius Medical Care, Roche, Sandoz Biopharmaceuticals, and Sanofi.

Publisher Copyright:
© 2016 International Society of Nephrology

Keywords

acute kidney injury
advocacy
chronic kidney disease
clinical practice guidelines
implementation
low and middle income countries

Publisher link

10.1016/j.kint.2016.09.009

Find It

Find It at U of M Libraries

Cite this

Jha, V., Arici, M., Collins, A. J., Garcia-Garcia, G., Hemmelgarn, B. R., Jafar, T. H., Pecoits-Filho, R., Sola, L., Swanepoel, C. R., Tchokhonelidze, I., Wang, A. Y. M., Kasiske, B. L., Wheeler, D. C., Spasovski, G., Agodoa, L., Ahmad, G., Anantharaman, V., Arogundade, F., Ashuntantang, G., ... Zakharova, E. (2016). Understanding kidney care needs and implementation strategies in low- and middle-income countries: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference. Kidney international, 90(6), 1164-1174. https://doi.org/10.1016/j.kint.2016.09.009

Understanding kidney care needs and implementation strategies in low- and middle-income countries : conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference. / Jha, Vivekanand; Arici, Mustafa; Collins, Allan J.; Garcia-Garcia, Guillermo; Hemmelgarn, Brenda R.; Jafar, Tazeen H.; Pecoits-Filho, Roberto; Sola, Laura; Swanepoel, Charles R.; Tchokhonelidze, Irma; Wang, Angela Yee Moon; Kasiske, Bertram L.; Wheeler, David C.; Spasovski, Goce; Agodoa, Lawrence; Ahmad, Ghazali; Anantharaman, Vathsala; Arogundade, Fatiu; Ashuntantang, Gloria; Ballal, Sudarshan; Bamgboye, Ebun; Banchuin, Chatri; Bogov, Boris; Bunnag, Sakarn; Chailimpamontri, Worawon; Chawanasuntorapoj, Ratana; Claure-Del Granado, Rolando; Eiam-Ong, Somchai; Gomez, Lynn; Gómez, Rafael; Goumenos, Dimitrios; Phan, Hai An Ha; Imonje, Valentine; Ingsathit, Atiporn; Jarraya, Faiçal; Jiwakanon, Sirin; Kantachuvesiri, Surasak; Khanna, Umesh; Kher, Vijay; Kitositrangsikun, Kamol; Liu, Zhi Hong; Lorvinitnun, Pichet; Nseka, Nazaire; Obrador, Gregorio T.; Okpechi, Ikechi; Onsuwan, Duangta; Ophascharoensuk, Vuddhidej; Osafo, Charlotte; Peiris, David; Pichaiwong, Warangkana; Praditpornsilpa, Kearkiat; Rajapurkar, Mohan; Rychlik, Ivan; Saadi, Gamal; Polo, Vicente Sanchez; Sangthawan, Pornpen; Suwan, Nirut; Tesar, Vladimir; Thirakhupt, Prapaipim; Trakarnvanich, Thananda; Tsukamoto, Yusuke; Tungsanga, Kriang; Vanichakarn, Supat; Vazelov, Evgueniy; Wanner, Christoph; Were, Anthony; Zakharova, Elena.

In: Kidney international, Vol. 90, No. 6, 01.12.2016, p. 1164-1174.

Research output: Contribution to journal › Article › peer-review

Jha, V, Arici, M, Collins, AJ, Garcia-Garcia, G, Hemmelgarn, BR, Jafar, TH, Pecoits-Filho, R, Sola, L, Swanepoel, CR, Tchokhonelidze, I, Wang, AYM, Kasiske, BL, Wheeler, DC, Spasovski, G, Agodoa, L, Ahmad, G, Anantharaman, V, Arogundade, F, Ashuntantang, G, Ballal, S, Bamgboye, E, Banchuin, C, Bogov, B, Bunnag, S, Chailimpamontri, W, Chawanasuntorapoj, R, Claure-Del Granado, R, Eiam-Ong, S, Gomez, L, Gómez, R, Goumenos, D, Phan, HAH, Imonje, V, Ingsathit, A, Jarraya, F, Jiwakanon, S, Kantachuvesiri, S, Khanna, U, Kher, V, Kitositrangsikun, K, Liu, ZH, Lorvinitnun, P, Nseka, N, Obrador, GT, Okpechi, I, Onsuwan, D, Ophascharoensuk, V, Osafo, C, Peiris, D, Pichaiwong, W, Praditpornsilpa, K, Rajapurkar, M, Rychlik, I, Saadi, G, Polo, VS, Sangthawan, P, Suwan, N, Tesar, V, Thirakhupt, P, Trakarnvanich, T, Tsukamoto, Y, Tungsanga, K, Vanichakarn, S, Vazelov, E, Wanner, C, Were, A & Zakharova, E 2016, 'Understanding kidney care needs and implementation strategies in low- and middle-income countries: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference', Kidney international, vol. 90, no. 6, pp. 1164-1174. https://doi.org/10.1016/j.kint.2016.09.009

Jha, Vivekanand ; Arici, Mustafa ; Collins, Allan J. ; Garcia-Garcia, Guillermo ; Hemmelgarn, Brenda R. ; Jafar, Tazeen H. ; Pecoits-Filho, Roberto ; Sola, Laura ; Swanepoel, Charles R. ; Tchokhonelidze, Irma ; Wang, Angela Yee Moon ; Kasiske, Bertram L. ; Wheeler, David C. ; Spasovski, Goce ; Agodoa, Lawrence ; Ahmad, Ghazali ; Anantharaman, Vathsala ; Arogundade, Fatiu ; Ashuntantang, Gloria ; Ballal, Sudarshan ; Bamgboye, Ebun ; Banchuin, Chatri ; Bogov, Boris ; Bunnag, Sakarn ; Chailimpamontri, Worawon ; Chawanasuntorapoj, Ratana ; Claure-Del Granado, Rolando ; Eiam-Ong, Somchai ; Gomez, Lynn ; Gómez, Rafael ; Goumenos, Dimitrios ; Phan, Hai An Ha ; Imonje, Valentine ; Ingsathit, Atiporn ; Jarraya, Faiçal ; Jiwakanon, Sirin ; Kantachuvesiri, Surasak ; Khanna, Umesh ; Kher, Vijay ; Kitositrangsikun, Kamol ; Liu, Zhi Hong ; Lorvinitnun, Pichet ; Nseka, Nazaire ; Obrador, Gregorio T. ; Okpechi, Ikechi ; Onsuwan, Duangta ; Ophascharoensuk, Vuddhidej ; Osafo, Charlotte ; Peiris, David ; Pichaiwong, Warangkana ; Praditpornsilpa, Kearkiat ; Rajapurkar, Mohan ; Rychlik, Ivan ; Saadi, Gamal ; Polo, Vicente Sanchez ; Sangthawan, Pornpen ; Suwan, Nirut ; Tesar, Vladimir ; Thirakhupt, Prapaipim ; Trakarnvanich, Thananda ; Tsukamoto, Yusuke ; Tungsanga, Kriang ; Vanichakarn, Supat ; Vazelov, Evgueniy ; Wanner, Christoph ; Were, Anthony ; Zakharova, Elena. / Understanding kidney care needs and implementation strategies in low- and middle-income countries : conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference. In: Kidney international. 2016 ; Vol. 90, No. 6. pp. 1164-1174.

@article{eadf8e03c09a47ddb1ec64c7f9652cff,

title = "Understanding kidney care needs and implementation strategies in low- and middle-income countries: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference",

abstract = "Evidence-based cinical practice guidelines improve delivery of uniform care to patients with and at risk of developing kidney disease, thereby reducing disease burden and improving outcomes. These guidelines are not well-integrated into care delivery systems in most low- and middle-income countries (LMICs). The KDIGO Controversies Conference on Implementation Strategies in LMIC reviewed the current state of knowledge in order to define a road map to improve the implementation of guideline-based kidney care in LMICs. An international group of multidisciplinary experts in nephrology, epidemiology, health economics, implementation science, health systems, policy, and research identified key issues related to guideline implementation. The issues examined included the current kidney disease burden in the context of health systems in LMIC, arguments for developing policies to implement guideline-based care, innovations to improve kidney care, and the process of guideline adaptation to suit local needs. This executive summary serves as a resource to guide future work, including a pathway for adapting existing guidelines in different geographical regions.",

keywords = "acute kidney injury, advocacy, chronic kidney disease, clinical practice guidelines, implementation, low and middle income countries",

author = "Vivekanand Jha and Mustafa Arici and Collins, {Allan J.} and Guillermo Garcia-Garcia and Hemmelgarn, {Brenda R.} and Jafar, {Tazeen H.} and Roberto Pecoits-Filho and Laura Sola and Swanepoel, {Charles R.} and Irma Tchokhonelidze and Wang, {Angela Yee Moon} and Kasiske, {Bertram L.} and Wheeler, {David C.} and Goce Spasovski and Lawrence Agodoa and Ghazali Ahmad and Vathsala Anantharaman and Fatiu Arogundade and Gloria Ashuntantang and Sudarshan Ballal and Ebun Bamgboye and Chatri Banchuin and Boris Bogov and Sakarn Bunnag and Worawon Chailimpamontri and Ratana Chawanasuntorapoj and {Claure-Del Granado}, Rolando and Somchai Eiam-Ong and Lynn Gomez and Rafael G{\'o}mez and Dimitrios Goumenos and Phan, {Hai An Ha} and Valentine Imonje and Atiporn Ingsathit and Fai{\c c}al Jarraya and Sirin Jiwakanon and Surasak Kantachuvesiri and Umesh Khanna and Vijay Kher and Kamol Kitositrangsikun and Liu, {Zhi Hong} and Pichet Lorvinitnun and Nazaire Nseka and Obrador, {Gregorio T.} and Ikechi Okpechi and Duangta Onsuwan and Vuddhidej Ophascharoensuk and Charlotte Osafo and David Peiris and Warangkana Pichaiwong and Kearkiat Praditpornsilpa and Mohan Rajapurkar and Ivan Rychlik and Gamal Saadi and Polo, {Vicente Sanchez} and Pornpen Sangthawan and Nirut Suwan and Vladimir Tesar and Prapaipim Thirakhupt and Thananda Trakarnvanich and Yusuke Tsukamoto and Kriang Tungsanga and Supat Vanichakarn and Evgueniy Vazelov and Christoph Wanner and Anthony Were and Elena Zakharova",

note = "Funding Information: VJ declared having received research support from Baxter and GlaxoSmithKline. AJC declared having received consultancy fees from AstraZeneca, Bayer, Gilead, and Relypsa. GG-G declared having received consultancy fees from Pisa Farmaceutica and speaker honoraria from Abbvie. THJ declared having received research support from Wellcome Trust UK, Medical Research Council, Department for International Development, and Singapore Ministry of Health. RP-F declared having received consultancy fees from Akebia and Janssen; speaker honoraria from AstraZeneca, Janssen, and Novartis; and research support from Fresenius. CRS declared having received consultancy fees from Fresenius. AYMW declared having received speaker honoraria from Sanofi. DCW declared having received consultancy fees from Akebia, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, GlaxoSmithKline, Janssen, Otsuka, UCB Celltech, and Vifor; speaker honoraria from Amgen, Fresenius, Janssen, Vifor, and ZS Pharma; and research support from British Heart Foundation, Healthcare Quality Improvement Partnership, Kidney Research UK, National Institute for Health Research, and Australian National Health & Medical Research Council. All the other authors declared no competing interests. Funding Information: The conference was sponsored by KDIGO and supported in part by unrestricted educational grants from Fresenius Medical Care, Roche, Sandoz Biopharmaceuticals, and Sanofi. Publisher Copyright: {\textcopyright} 2016 International Society of Nephrology",

year = "2016",

month = dec,

day = "1",

doi = "10.1016/j.kint.2016.09.009",

language = "English (US)",

volume = "90",

pages = "1164--1174",

journal = "Kidney International",

issn = "0085-2538",

publisher = "Nature Publishing Group",

number = "6",

}

TY - JOUR

T1 - Understanding kidney care needs and implementation strategies in low- and middle-income countries

T2 - conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

AU - Jha, Vivekanand

AU - Arici, Mustafa

AU - Collins, Allan J.

AU - Garcia-Garcia, Guillermo

AU - Hemmelgarn, Brenda R.

AU - Jafar, Tazeen H.

AU - Pecoits-Filho, Roberto

AU - Sola, Laura

AU - Swanepoel, Charles R.

AU - Tchokhonelidze, Irma

AU - Wang, Angela Yee Moon

AU - Kasiske, Bertram L.

AU - Wheeler, David C.

AU - Spasovski, Goce

AU - Agodoa, Lawrence

AU - Ahmad, Ghazali

AU - Anantharaman, Vathsala

AU - Arogundade, Fatiu

AU - Ashuntantang, Gloria

AU - Ballal, Sudarshan

AU - Bamgboye, Ebun

AU - Banchuin, Chatri

AU - Bogov, Boris

AU - Bunnag, Sakarn

AU - Chailimpamontri, Worawon

AU - Chawanasuntorapoj, Ratana

AU - Claure-Del Granado, Rolando

AU - Eiam-Ong, Somchai

AU - Gomez, Lynn

AU - Gómez, Rafael

AU - Goumenos, Dimitrios

AU - Phan, Hai An Ha

AU - Imonje, Valentine

AU - Ingsathit, Atiporn

AU - Jarraya, Faiçal

AU - Jiwakanon, Sirin

AU - Kantachuvesiri, Surasak

AU - Khanna, Umesh

AU - Kher, Vijay

AU - Kitositrangsikun, Kamol

AU - Liu, Zhi Hong

AU - Lorvinitnun, Pichet

AU - Nseka, Nazaire

AU - Obrador, Gregorio T.

AU - Okpechi, Ikechi

AU - Onsuwan, Duangta

AU - Ophascharoensuk, Vuddhidej

AU - Osafo, Charlotte

AU - Peiris, David

AU - Pichaiwong, Warangkana

AU - Praditpornsilpa, Kearkiat

AU - Rajapurkar, Mohan

AU - Rychlik, Ivan

AU - Saadi, Gamal

AU - Polo, Vicente Sanchez

AU - Sangthawan, Pornpen

AU - Suwan, Nirut

AU - Tesar, Vladimir

AU - Thirakhupt, Prapaipim

AU - Trakarnvanich, Thananda

AU - Tsukamoto, Yusuke

AU - Tungsanga, Kriang

AU - Vanichakarn, Supat

AU - Vazelov, Evgueniy

AU - Wanner, Christoph

AU - Were, Anthony

AU - Zakharova, Elena

N1 - Funding Information: VJ declared having received research support from Baxter and GlaxoSmithKline. AJC declared having received consultancy fees from AstraZeneca, Bayer, Gilead, and Relypsa. GG-G declared having received consultancy fees from Pisa Farmaceutica and speaker honoraria from Abbvie. THJ declared having received research support from Wellcome Trust UK, Medical Research Council, Department for International Development, and Singapore Ministry of Health. RP-F declared having received consultancy fees from Akebia and Janssen; speaker honoraria from AstraZeneca, Janssen, and Novartis; and research support from Fresenius. CRS declared having received consultancy fees from Fresenius. AYMW declared having received speaker honoraria from Sanofi. DCW declared having received consultancy fees from Akebia, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, GlaxoSmithKline, Janssen, Otsuka, UCB Celltech, and Vifor; speaker honoraria from Amgen, Fresenius, Janssen, Vifor, and ZS Pharma; and research support from British Heart Foundation, Healthcare Quality Improvement Partnership, Kidney Research UK, National Institute for Health Research, and Australian National Health & Medical Research Council. All the other authors declared no competing interests. Funding Information: The conference was sponsored by KDIGO and supported in part by unrestricted educational grants from Fresenius Medical Care, Roche, Sandoz Biopharmaceuticals, and Sanofi. Publisher Copyright: © 2016 International Society of Nephrology

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Evidence-based cinical practice guidelines improve delivery of uniform care to patients with and at risk of developing kidney disease, thereby reducing disease burden and improving outcomes. These guidelines are not well-integrated into care delivery systems in most low- and middle-income countries (LMICs). The KDIGO Controversies Conference on Implementation Strategies in LMIC reviewed the current state of knowledge in order to define a road map to improve the implementation of guideline-based kidney care in LMICs. An international group of multidisciplinary experts in nephrology, epidemiology, health economics, implementation science, health systems, policy, and research identified key issues related to guideline implementation. The issues examined included the current kidney disease burden in the context of health systems in LMIC, arguments for developing policies to implement guideline-based care, innovations to improve kidney care, and the process of guideline adaptation to suit local needs. This executive summary serves as a resource to guide future work, including a pathway for adapting existing guidelines in different geographical regions.

AB - Evidence-based cinical practice guidelines improve delivery of uniform care to patients with and at risk of developing kidney disease, thereby reducing disease burden and improving outcomes. These guidelines are not well-integrated into care delivery systems in most low- and middle-income countries (LMICs). The KDIGO Controversies Conference on Implementation Strategies in LMIC reviewed the current state of knowledge in order to define a road map to improve the implementation of guideline-based kidney care in LMICs. An international group of multidisciplinary experts in nephrology, epidemiology, health economics, implementation science, health systems, policy, and research identified key issues related to guideline implementation. The issues examined included the current kidney disease burden in the context of health systems in LMIC, arguments for developing policies to implement guideline-based care, innovations to improve kidney care, and the process of guideline adaptation to suit local needs. This executive summary serves as a resource to guide future work, including a pathway for adapting existing guidelines in different geographical regions.

KW - acute kidney injury

KW - advocacy

KW - chronic kidney disease

KW - clinical practice guidelines

KW - implementation

KW - low and middle income countries

UR - http://www.scopus.com/inward/record.url?scp=84997327482&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84997327482&partnerID=8YFLogxK

U2 - 10.1016/j.kint.2016.09.009

DO - 10.1016/j.kint.2016.09.009

M3 - Article

C2 - 27884311

AN - SCOPUS:84997327482

VL - 90

SP - 1164

EP - 1174

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 6

ER -

Understanding kidney care needs and implementation strategies in low- and middle-income countries: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

Abstract

Bibliographical note

Keywords

Publisher link

Find It

Other files and links

Fingerprint

Cite this